Research FeaturesUnlocking erlotinib’s full potential: A new frontier in lung cancer therapyLung cancer presents significant treatment challenges due to limited effectiveness and adverse effects of current therapies.Aug 7
Directive Publications, Open Access JournalsThe European Journal of CancerThe European Journal of Cancer (ISSN 3064–6731) is a peer-reviewed medical journal that publishes high-quality research on all aspects of…Nov 22
Research FeaturesFighting cancer with smart bullets: The antibody-drug conjugates revolutionAntibody-drug conjugates (ADCs) hold promise in cancer therapy, targeting malignant cells via a surface protein called the Epidermal Growth…Dec 27, 2023Dec 27, 2023
Drive Growth | Devang Soni#6 — The Transformative Impact of a New Cancer Drug: A Case Study of Toripalimab and its 30X cost…With the recent approval of Chinese cancer drug Toripalimab by the FDA (Food and Drug Administration) in the United States, it marks a…Nov 30, 2023Nov 30, 2023
Research FeaturesUnlocking erlotinib’s full potential: A new frontier in lung cancer therapyLung cancer presents significant treatment challenges due to limited effectiveness and adverse effects of current therapies.Aug 7
Directive Publications, Open Access JournalsThe European Journal of CancerThe European Journal of Cancer (ISSN 3064–6731) is a peer-reviewed medical journal that publishes high-quality research on all aspects of…Nov 22
Research FeaturesFighting cancer with smart bullets: The antibody-drug conjugates revolutionAntibody-drug conjugates (ADCs) hold promise in cancer therapy, targeting malignant cells via a surface protein called the Epidermal Growth…Dec 27, 2023
Drive Growth | Devang Soni#6 — The Transformative Impact of a New Cancer Drug: A Case Study of Toripalimab and its 30X cost…With the recent approval of Chinese cancer drug Toripalimab by the FDA (Food and Drug Administration) in the United States, it marks a…Nov 30, 2023
AKcreatesRevolutionizing Cancer Treatment: The Dostarlimab BreakthroughAre you tired of the same old cancer treatments? Well, get ready to have your mind blown because we have a game-changer for you…Aug 10, 20232
Richard A MeyerWhat’s causing the cancer drug shortage?The nation’s monthslong shortage of highly potent cancer drugs is grinding on, forcing patients and their doctors to face even grimmer…Jul 19, 2023
Avestria VenturesUnder the Microscope: ENB TherapeuticsENB is developing small molecule drugs to treat melanoma, ovarian, pancreatic, and other drug-resistant cancers.Nov 3, 2022
